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Abstract. F/'actionated extracts of Feljoa peels were studied 
for cytotoxic activity, anti-human immunodeficiency virus 
(HIV) activity and antibacte/'ial activity. Two lnost cytotoxic 
fi'actions A3 of acetone extract and M2 of methanol extract 
had potent inh,ibitory activity against G,'am-positive an,d 
G,'am-negative bacteria as 'vell as fungi tested. Fra.ction A4 o.f 
acetone extract showed multidrug resistance (MDR)-reversal 
activity comparable with. that of verapamil (positive cont/'ol). 
These results indicate the the"apeutic value of Feljoa peel 
extracts as potential antimicrobial and MDR-modulating 
agents. 
Feijoa sellowiana Berg (Myrtaceae) has been cultured 
mainly in the tropics and subtropics such as south Brazil, 
Uruguay, Paraguay and North Argentina. Feijoa has a 
pleasant flavour and is also eaten stewed, in jams, jelly or 
juice. Feijoa contains many medicinally bioactive 
compounds. 
The predominant aroma of Feijoa fruits is ascribed to 
methylbenzoate and ethylbenzoate (1, 2). Other volatile 
components were also identified (3-7). Feijoa is rich in 
vitamin P (P)-active polyphenols, such as catechin, 
leucoanthocyanins, flavonols, proanthocyanid.ins and 
naphthoquinones (8-11). The Feijoa leaves of also contain 
catechins such as (+)-catechin, (-)-epicatechin, (+)-
gallocatechin and (-)-epigallocatechin (12). Furthermore, 
tannins in Feijoa fruits and leaves have been identified 
(13). The flower part of Feijoa contains anthocyanin-3-
glucoside of polyphenols (14). Feijoa fruits are rich in 
vitam n C (8, 10, 15-17). Especially, a concentrated juice of 
Feijoa has 3-times higher concentrations of vitamin C than 
fresh juice (5). Provitamin A such as ct-carotene, ~-
c rotene and ~-cryptoxanthin were also determined (18). 
Both water-insoluble and water-soluble fibers are found in 
Feijoa (17, 19). Amino acids such as tryptophan, Iysine, 
m thionine and asparagine with nutritional value were also 
extra ted from i a (17, 20). A recent study on the 
bi logical activities of an aqueous extract from Feijoa fruit 
has shown both antibacterial and antioxidant properties 
(21). 
In ddition, interestingly, Feijoa peel contains especially 
high amounts of vitamin C and catechin-like vitamin P (P)-
active polyphenols, such as leucoanthocyanins, flavonols 
a d naphthoquinon s (15). Although the chemical 
constitue ts of the Feijoa fruit have been reported, no 
detailed pharmaceutical study of the constituents of Feijoa 
peel has as yet been performed. 
The peel is generally regarded as a waste matter 
although, bi logically and nutritiously interesting 
compound  are rich in it. With this consideration in mind, 
we have screened for new biologically active agents from 
various fruits nd vegetables that are consumed by people. 
The purpose of t s paper was to study the cytotoxic 
ac ivity, anti-h man i munodeficiency virus (HIV) activity 
and antibacterial activity of Feijoa peel extracts. 
Materials and Methods 
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Materials. Feljoa sellowiana Berg was collected from Motohashi 
g rden in Tokyo. Voucher specimens of the plants were deposited at 
the herbarium of Josai University. 
Pr paration of Feljoa pee/ ext,'acts. Feijoa peel (330 g) was cut into 
small pieces and successively extracted with hexane, acetone, MeOH 
nd 70% MeOH at room temperature; the solvent was concentrated 
in vacuo and the hexane extract [HO](0.44 g), acetone extract [AOl(5.9 
g), MeOH extract [MO](16.7 g) and 70% MeOH extract [70MO](6.1 
g) ¥vere obtained, respectively. First, the aliquot of hexane extract 
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[HO](0.4 g) was applied to silica gel column chromatography, which 
was then eluted with a hexane-acetone gradient. The hexane fraction 
[Hlj(32 mg), hexane-acetone (9:1) fraction [H2](157 mg), hexane-
acetone (4:1) fraction [H3](47 mg) and [H4](45 mg) were eluted 
stepwise. Second, the acetone extract [AO](5.5 g) was applied to silica 
gel column chromatography, which was then eluted with a benzene-
AcOEt gradient. The benzene fraction [Al](92 mg), benzene-AcOEt 
(10:1) fraction [A2](103 mg), [A3](145 mg), benzene-AcOEt (1:1) 
fraction [A4](170 mg), AcOEt fraction[A5](582 mg), AcOEt-EtOH 
(5:1) fraction [A6](836 mg) and [A7](854 mg) were eiuted stepwise. 
Third, the MeOH extract [MO](16.7 g) was applied to silica gel 
column chromatography, which was then eluted with a CH2C12-
MeOH gradient. The CH2C12 fraction [Ml](24 mg), CH2C12-MeOH 
(50:1) fraction [M2](135 mg), CH2C12-MeOH (9:1) fraction [M3](25 
mg), [M41(761 mg), CH2C12-MeOH (4:1) fraction [M5](1317 mg) and 
[M6](2100 mg) were eluted stepwise. Finally, the 70% MeOH extract 
[70MO](5 g) was applied to ODS column chromatography, which was 
then eluted with a H20-MeOH gradient. The H20-MeOH (2:1) 
fraction [70Ml](2010 mg), [70M2](80 mg), H20-MeOH (1:1) 
fraction [70M3](18 mg), [70M4](43 mg) and MeOH fraction 
[70M5](1200 mg) were eluted stepwise (Figure 1). 
Assay fol' cytotoxic activity. Human oral squamous cell carcinoma 
(HSC-2) and human oral salivary gland tumor (HSG) cell lines and 
human oral gingival fibroblasts (HGF) (5-7 population doubling 
levels) were cultured in Dulbecco's modified Eagle medium (DMEM) 
(Gibco BRL, Grand Island, NY, U.S.A.) supplemented with 10% 
heat-inactivated fetal bovine serum (FBS) (JRH Biosci). These cells 
were incubated for 24 hours with the indicated concentrations of test 
samples and the viable cell number was then determined by 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
In brief, the cells were washed with phosphate-buffered saline (PBS) 
and incubated for 4 hours with fresh culture medium containing 0.2 
mg/mL MTT (Sigma Chem. Ind., St. Louis, MO, U.S.A.). After 
removing the medium, the cells were lysed with 100 ~tL DMSO and 
the absorbance at 54RO nm of the cell lysate was measured with 
Labsystems Mutiskan (Biochromatic) with StarIDOT Matrix printer 
JL-10. The 50% cytotoxic concentration (CC50) was determined from 
the dose-response curve. 
Assay fol' anti-HIV activity. The inhibition of HIV-induced cytopathic 
effects by Feijoa extracts was studied. Human T cell leukemia virus 1 
(HTLV1)-bearing CD4 positive human T cell lines, MT-4 cells, were 
infected with HIV-ImB at a multiplicity of infection (m.o.i.) of 0.01. 
HIV- or mock-infected MT-4 cells (1.5 x l05/mL, 200 uL) were placed 
into 96-well microtiter plates in RPMI 1640 medium supplemented 
with 10% heat-inactivated PBS and incubated in the presence of 
varying concentrations of the compounds tested. After incubation for 
5 days at 37'C in a C02 incubator, cell viability was quantified by a 
colorimetric assay (at 540 nm and 690 nm), monitoring the ability of 
viable cells to reduce MTT to a blue formazan product (22). All data 
represent the mean values of triplicate measurements. 
Bacterials. Escherichia coli L~; 140 F'Iac, Pseudomonas ae/'uginosa, 
Staphylococcus epide/?nidis. Candida albicans and Candida glabrata 
were isolated from clinical speciments obtained from the Department 
of Clinical Microbiology, Medical University of Szeged, Hungary. 
Helicobacter pylori (ATCC43504) was purchased from the American 
Type Culture Collection (Rockville, MD, U.S.A.). 
Measu/'ement of antibacterial activity. The experiments were made by 
adding 10 uL of original solutions as a droplet on a minimal medium 
supplemented with 1% trypton and 0.5%5yeast extract (MTE) broth 
and blood agar plates inoculated with 10 cells of the tested strains. 
The plates were incubated at 37'C for 24 hours, then the inhibitory 
zones were measured. As a control, 10 uL of DMSO was examined on 
each strain. It was found, that C. albicans, C. glabrata and P. 
ae,'ugin sa were sensitive to DMSO. The growth of E. coli and S. 
?
epide/?nidis was not inhibited by DMSO. An ampicillin disc was used 
as a positive control in the studies of antibacteriai effects. 
Measu/'ement of ant -H. pylo/i activity. The micro-dilution broth 
method was used to determine the minimum inhibitory concentration 
(MIC). Mueller-Hilton broth containing 5% FBS was used as the 
medium and was cultured in a jar conditioned with Campylo Pack 
(D a latron) for 48 hours. Briefly, H. pylol'i strains were inoculated on 
a Brucella agar plate containing 10% horse serum and cultured at 
37'C for 48 hours. The collected bacterial colonies were diluted to 
107 colony forming unit (UFU)/mL with 0.9% saline. The fractions 
were dissolved in DMSO and then diluted with Mueller-Hilton broth. 
To the solu6tion of the fractions, a suspension of bacteria was added 
to make 10 CFU/100 mL/well. The mixture was incubated at 37'C 
for 48 hours. The MIC values of the fractions tested were determined 
by observation. 
Cell and fluo,'escence uptake. MRD1/A expressing cell lines were 
selected by culturing the infected cells with 60 ng/mL colchicine to 
maintain the expression of the multidrug resistance (MDR) 
phenotype. The L5178 MDR cell line and the L5178 Y parent cell 
line were grown in McCoy's 5A medium supplemented with 10% 
heat-inactivated horse serum. L-glut6amine and antibiotics. The cells 
were adjusted to a density of 2 x 10 /mL and resuspended in serum-
free McCoy's 5A medium and an 0.5 mL aliquot of the cell 
suspension were distributed into each Eppendorf centrifuge tube. 
Then, 2 uL of 2 mg/mL each te t fraction was added and incubated 
for 10 min at room temperature. Then, 50 uL rhodamine 123 (R123) 
(5.2 ~tM final co centration) was added as indicator and the ce]Is 
we e inc bated for a further 20 minutes at 37'C. The cells were 
washed twice and re uspended in 0.5 mL phosphate-buffered saline 
(PBS) for the analysis of the fluorescence of cell population by flow 
cytometry (Beckton Dickinson FACScan). Verapamil was used as the 
positive control in R123 accumulation experiments. R123 
accumulation s measured by the fluorescence of the cells in argon 
laser. Then, the mean fluorescence intensity of the drug-treated cells 
was measured in par ntal and MDR cell lines, compared to untreated 
cells. The fluorescence activity ratio was calculated by using the 
following equation (23, 24): 
Ratio = (MDR treated / MDR control) / (parental treated / parental 
contro ) 
Results and Disc ssion 
Cytotoxic activity. It is widely accepted that in cancer cells, 
ma y anticancer agents act as apoptosis-inducers and the 
major reason for the unresponsiveness of cancer cells is the 
insufficiency of these drugs to trigger apoptosis (25). The 
cytotoxicity of all fractions was evaluated in two human 
oral tumor cell lines (HSG-2, HSG) and one human 
gingival ibroblast (HGF), using the microculture 
tetrazolium (MTT) ass y Crude hexane [HO], acetone 
[AO], MeOH [MO] and 70%MeOH [70MO] extracts showed 
weak cytotoxic activity against these cells. However, after 
separation by column chromatography (Figure 1), various 
levels of cytotoxic ctiv ties became detectable in several 
fractions (Table I). Mos  fractions exhibited only low 
cytotoxicity (IC50 values>100 ug/mL,). However, fractions 
A3 and M2 displayed the highest cytotoxic activity against 
both tumor ce l lines (HSC-2 and HSG) and the normal 
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Tzible I. Cytoto.vic and anli-HIVactil;ity; of Feljoa pec'l extracts against tumor a,rd no,??7a! cel/s. 
Fraction Cytotoxic activity (CC50, ug/mL) 
HO 
Ill 
H2 
H3 
H4 
AO 
A1 
A2 
A3 
A4 
A5 
A6 
A7 
MO 
Ml 
M2 
M3 
M4 
M5 
M6 
70MO 
70Ml 
70M2 
70M3 
70M4 
70M5 
CRDS 
DS 
AZT(uM) 
ddC (uM) 
HSC-2 
38i 
>500 
313 
>500 
?~69 
444 
l 60 
13'_ 
81 
274 
335 
>500 
>500 
> 500 
3 78 
l 19 
3, 38 
> 500 
>_500 
45 8 
380 
3 9(*) 
394 
25O 
208 
488 
HSG 
3, 86 
> _500 
357 
> 500 
356 
462 
_302 
1 23 
79 
_318 
383 
>500 
> 500 
> 500 
427 
101 
268 
458 
>500 
>500 
>500 
>500 
>500 
> 500 
280 
> 500 
HGlr~ 
395 
>500 
370 
>500 
409 
45 2 
30_~~ 
i. 65 
80 
382 
403 
> 500 
>500 
>50C) 
44 l 
i5･_ 
277 
235 
>500 
>500 
>500 
>500 
> 500 
>500 
419 
>500 
SI (HGF/HSC-2) 
1 .O 
><1 
l.2 
><l 
i .5 
1.0 
l.O 
i.3 
l. .O 
1.4 
1,2 
><l 
><1 
><l 
l.2 
l .3 
O.8 
<0.5 
><l 
><1.l 
> I .3 
> I .3 
> I ._3 
>2 
2.0 
> I .O 
CC50 (~tg/mL) 
1 OO 
> 200 
i6･_ 
> '_OO 
117 
1 19 
l 21 
ll3 
22 
46 
l '_7 
> 200 
> 200 
> 200 
> 200 
l 20 
78 
> 200 
> ?_OO 
> 200 
> 200 
> 200 
99 
83 
1 O?_ 
> 200 
> 1000 
> 1000 
268 
2395 
Anti-HIV ･activity 
EC_~-o (ug/mL) 
> 200 
> 200 
> 200 
> 200 
> 200 
> 200 
> 200 
> 200 
> 40 
> 200 
> '_OO 
> 200 
> 200 
> 20O 
> 200 
> 200 
> 200 
> 200 
> 200 
> 200 
> 200 
> 200 
1_5 
> 200 
> 200 
> 200 
1.1614 
1 3.9969 
O.3402 
6.6587 
SI (CC50/EC50) 
<1 
><l 
<1 
><1 
<1 
<1 
<1 
<l 
<1 
<1 
<i 
><1 
><i 
><l 
><1 
<l 
<1 
><1 
><1 
><1 
><1 
><1 
?
<1 
<1 
><l 
86 1 
>71 
787 
36C) 
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Feijoa peel (330g) 
extracted with hexane 
1 ) Hexane ext. (HO) (0.44 g) 
(0.4 g) silica gel OC eluted 
with hexane-acetone 
H1 (32 mg) 
H2 (157 mg) 
H3 (47 mg) 
H4 (45 mg) 
extracted with acetone 
2) Acetone ext. (AO) (5.9 g) 
(5.5 g) siiica gel CC eluted 
with benzene-AoOEt 
A1 (92 mg) 
A2 (1 03 mg) 
A3 (1 45 mg) 
A4 (170 mg) 
A5 (582 mg) 
A6 (836 mg) 
A7 (854 mg) 
extracted with MeOH 
3) MeOH ext. (MO)(1 6.7 g) 
(16.7 g) silica gel CC eluted 
with CH2012-MeOH 
extracted with 70'/･ MeOH 
M1 (24 mg) 
M2 (1 35 mg) 
M3 (25 mg) 
M4 (761 mg) 
M5 (1317 mg) 
M6 (2100 mg) 
4) 70'10 MeOH ext. (70MO)(6.1 
(5 g) ODS OC eluted 
g) with MeOH-H20 
70M1 (2010 mg) 
70M2 (80 mg) 
70M3 (1 8 mg) 
70M4 (43 mg) 
70M5 (1200 mg) 
Figure I . Fractional separation of Feljoa peel extracts. CC.' column chromatography. 
fibroblast (HGF). When the water solubility of the test 
fraction was increased, the relative cytotoxic activity against 
normal cells (SI=HGF/HSC-2) generally declined (Table I). 
Anti-HIV activity. Table I shows that most of the fractions 
failed to inhibit HIV-induced cytopathic effects on MT-4 
cells (selectivity index (SI)=1), compared to the higher 
anti-HIV activities of curdlan sulfate (CRDS), dextran 
sulfate (DS), AZT and ddC (SI=71-861). However, 
fraction 70M2, which has relatively higher water-
solubility, showed some anti-HIV activity (SI=7) (Table 
I). This is consistent with our previous findings that the 
anti-HIV activity increased with water-solubility of the 
compound : in the order of lignin (26) > hydrolyzable 
tannins > condensed tannins (22). Higher molecular 
weight lignins and tannins showed higher anti-HIV 
activity in comparison with their lower molecular weight 
compounds (22, 26). 
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Table ll. Antibact,?rial activty o/'Feljoa pee! (･xtiY;lcts. 
Fraction 
HO 
Hl 
H2 
H3 
H4 
Sta ph y'!ococcl!s 
epid ennid is 
+ 
E. coli 
?
+ 
+ 
Pseud omonas 
a eru '~in osa 
Ca n d id a 
albicans 
?
Ca n d id a 
g/ ab,~:Ita 
He!icobacte/ ' 
py!o,i (MIC50, ~t~nlL) 
NDb 
> 100 
> I OO 
> I OO 
> I OO 
AO 
A1 
A2 
A3 
A4 
A5 
A6 
A7 
++ 
+-
++ 
++ 
++ 
+ 
?
++ 
++ 
++ + 
NDb 
> I OO 
> 100 
> I OO 
>100 
> lO() 
> i OO 
> 1O() 
MO 
Ml 
M2 
M3 
M4 
M5 
M6 
+ 
??
++ 
+-
?
?
+ 
++ 
? + 
NDi' 
> 100 
> I OO 
> 100 
> I OO 
> I OO 
> 100 
70MO 
70Ml 
70M2 
70M3 
70M4 
70M5 
?
?
+ 
?
NDt, 
> I OO 
> I OO 
> I OO 
> I OO 
> I OO 
Metronidazole 
Charithromycin 
Erythromycin 
+ + very potellt; + poten 
a inhibited haemolysis. ??
Not cictected. 
: +- s iightly potent: - no effect. 
74 
l .9 
l .8 
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Antibacte/"ial activity. Chemotherapy with antibiotics 
sometimes possesses serious side effects such as diarrhea, 
nausea, abnormal taste, dyspepsia, abdominal pain/ 
discomfort, headache and angioedema. Therefore, there is 
a strong demand for the predominance of beneficial effects 
of antibacterial agents over their side effects. In this sense 
the antibacterial activity of fruit or vegetable extracts may 
be superior as compared to many antibiotics. A11 fractions 
were tested against a panel of microorganisms, including 
the Gram-positive bacteria, Staphylococcus epidermidis and 
Gram-negative bacteria, Escherichia coli. and Pseudomonas 
aeruginosa and the fungi, Candida albicans and Candida 
glabrata (Table II). The highest activities consistently 
resided in the acetone and MeOH extract fractions. Two 
fractions [A3] and [M2] were found to exhibit potent 
activity against both Gram-positive and -negative bacteria 
as well as against fungi. 
Anti-Helicobacter pylori activity. The current medical 
consensus shows that H. pylori is the primary causative 
agent of acute gastritis (27). Since the drug will directly 
come in contact with the lining of the stomach, edible 
plants may be a good source of oral antiulcer agents. 
However, all fractions did not exhibit potent anti-H. pylol'i 
activity (MIC50>100 ug/mL), in contrast to three effective 
positive controls: metronidazole, clarithromycin and 
erythromycin (Table II). 
MDR /'eversal on tumor cells. Emerging drug resistance is 
known among viruses, bacteria, protozoa and cancer cells 
including retroviruses such as the HIV. The development 
of potent MDR inhibitors devoid of other toxicities has 
become a desirable goal to test the MDR-reversal 
hypothesis in the clinic. 
Rhodamine 123 assay has been widely accepted as a direct 
and reproducible assay for measuring P-gycoprotein (Pgp)-
dependent efflux (28). We measured the ability of the 
fractions to inhibit Pgp-mediated R-123 efflux in the MDR 
mouse T cell lymphoma L5178 transfected by human MDR 1 
gene which was cultured in colchicine containing medium 
(Table 111). Fraction A4 had the highest MDR reversal 
activity (ratio: 19.90) among all fractions and was 1.3 times 
more potent than that of verapamil (ratio: 16.16), followed by 
fractions [H3 (ratio: 4.55), H4 (ratio: 5.38), A5 (ratio: 5.07) 
and 70M4 (ratio: 9.34)]. It is clear that fraction A4 was 
superior to all other fractions of Feijoa. 
In conclusion, Feijoa peel extract has various bioactive 
components: Fractions A3 and M2 were not only 
cytotoxic, but also showed promising antibacterial 
activity. Fraction A4 showed exceptionally promising 
levels of MDR-modulating activity. The results of this 
study apparently indicate the therapeutic value of Feijoa 
peel extracts. Further work is required to identify and 
isolate the compounds responsible for the reported 
biological activity. 
Table 111. 
51 78 cells. 
Fraction 
Effect of Feljo  peel extract  on the multi-drug resistance of L-
Concentration 
(u~mL) 
Par (control) b 
MDR+R123 (control)* 
MDR+R123 (control) 
MDR+R123 (m an) 
(dl)=Verapamil 
HO 
H1 
H2 
H3 
H4 
AO 
A1 
A2 
A3 
A4 
A5 
A6 
A7 
MO 
M1 
M2 
M3
M4 
M5 
M6 
70MO 
70M1 
70M2
70M3 
70M4 
70M5 
?
?
?
10 
10 
10 
l O 
10 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
20 
FSCa
394 
377
448 
413 
415 
331 
301 
317 
296 
29 3 
306 
377
362 
332 
395 
305 
353 
379 
336 
345 
27 3 
311 
25 4 
266 
311 
506 
46 1 
470 
420 
485 
416
SSCa 
131 
1 40 
1 43 
1 42 
110 
363 
298 
227 
300 
331 
141 
173 
156 
152 
349 
168 
141 
141 
245 
23 6 
204 
233 
273 
236 
27
113 
113 
1 24 
1 07 
135 
110 
FL-1a 
4104.0 
63.2 
41.0 
52.1 
842.0 
821 
25 1 
311 
1 206 
1419 
90 
1 90 
183 
1 65 
980 
249 
74 
74 
131 
188 
207 
807 
260 
109 
199 
95 
80 
78 
86 
973 
61 
FSC: Forward scatter count; SSC: Side scatter 
Fluorescence intensity. 
Par: a parental cell without MDR gene. 
MDR: a parental cell transfected with MDR gene. 
Huorescence 
activity ratio 
78.77 
1.21 
0.79 
1 .OO 
16.16 
3,09 
O.94 
1.17 
4,55 
5.35 
1.82 
3.86 
3.72 
3.30 
19.90 
5.07 
1.49 
1.49 
0.49 
0.71 
0.78 
3.04 
0.98 
0.41 
0.74 
0.91 
O.77 
0.75 
0.83 
9.36 
0.59 
count; FL- I : 
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